BioTE® सार्वजनिक
[search 0]
अधिक
Download the App!
show episodes
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
The Biotech Startups Podcast

Excedr

Unsubscribe
Unsubscribe
साप्ताहिक+
 
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
  continue reading
 
Artwork
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
Artwork

1
Business Of Biotech

Matt Pillar

Unsubscribe
Unsubscribe
साप्ताहिक
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Artwork

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
मासिक
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
  continue reading
 
Artwork

1
BioTech Nation ... with Dr. Moira Gunn

Moira Gunn

Unsubscribe
Unsubscribe
साप्ताहिक
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Artwork

1
Grow Everything Biotech Podcast

Messaginglab

Unsubscribe
Unsubscribe
साप्ताहिक
 
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
  continue reading
 
Artwork

1
Biotech Career Coach

Carina Clingman

Unsubscribe
Unsubscribe
मासिक+
 
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
  continue reading
 
Artwork

1
Building Biotechs

Recruitomics Consulting

Unsubscribe
Unsubscribe
मासिक+
 
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
  continue reading
 
Artwork

1
Podcast Biotec

SoyBiotec

Unsubscribe
Unsubscribe
रोज+
 
SoyBiotec, es decir, Biotecnólogo. Estudio Biotecnología en mis ratos libres y cuando no, os la cuento por aquí. SoyBiotec y Podcast Biotec son ideas originales de Dani García
  continue reading
 
Artwork

1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado

Unsubscribe
Unsubscribe
साप्ताहिक+
 
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
  continue reading
 
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
  continue reading
 
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
  continue reading
 
Artwork

1
The Biotech Futurist

thebiotechfuturistpodcast

Unsubscribe
Unsubscribe
मासिक
 
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
  continue reading
 
Artwork

1
The Longevity Biotech Show

The Longevity Biotech Show

Unsubscribe
Unsubscribe
मासिक
 
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
  continue reading
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
  continue reading
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
  continue reading
 
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
  continue reading
 
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
  continue reading
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
  continue reading
 
Loading …
show series
 
This week on BioTech Nation, we talk with Dr. Eben Kirksey about the ethical issues behind CRISPR, the gene-editing tool that made headlines with the birth of the first “CRISPR babies” in China. Dr. Kirksey shares his experiences investigating this controversial experiment and highlights the deeper questions it raises. He stresses the importance of…
  continue reading
 
Synopsis: Rob Williamson, CEO of Triumvira, joins Biotech 2050 host, Rahul Chaturvedi, to discuss his dynamic career from economics to biotech, tackling the volatile capital markets, and navigating high-stakes decisions in cell therapy. He shares insights on therapeutic developments in cell therapy, the pressures of solid tumor research, and the ev…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Beam Therapeutics reported a patient death in a gene editing trial for sickle cell disease, overshadowing otherwise positive data. Beam-101 was found to be competitive with approved treatments, highlighting the need for les…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viking Therapeutics has reported promising phase I data for their oral weight loss drug, VK2735, with patients on 100-miligram doses losing 8.2% of their body weight after 28 days. Jefferies analyst Roger Song described th…
  continue reading
 
Send us a text In this insightful episode, we're joined by Sigma Mostafa, Chief Scientific Officer at KBI Biopharma, who shares crucial insights on selecting the right CDMO partner for biotech development. Sigma brings a unique blend of scientific rigor and practical experience to the discussion, having worked on both sides of the CDMO relationship…
  continue reading
 
The relationship between biotech leadership and their boards is evolving, particularly as private equity takes a larger role in the industry. In this episode of the Emerging Biotech Leader, Nick Amigone from Amulet Capital Partners offers a unique perspective on building effective board relationships from the private equity vantage point. The conve…
  continue reading
 
We love to hear from our listeners. Send us a message. Becoming a biotech CEO wasn't on Paul Romness' bingo card. He'd forged his place in the biopharma industry as a foremost public and policy affairs expert. Thirteen years at J&J, more than 5 at Amgen, and half a dozen at Boehringer Ingelheim had earned him the right to coast into a consulting gi…
  continue reading
 
The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸. Get your unique referr…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo Nordisk's weight loss drug Wegovy showed significant improvement in liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis in a Phase III trial. Bristol Myers Squibb reported strong third-qu…
  continue reading
 
Rocky Graziose from Estée Lauder is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how Estée Lauder’s commit…
  continue reading
 
Sitryx Therapeutics is a private UK biopharma company founded in 2018. It is a leader in the field of immunometabolism, an area of immunology that looks to rebalance the immune system to achieve sustained disease remission in autoimmune and inflammatory diseases. Sitryx already has big pharma validation following a deal with Eli Lilly in 2020 worth…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Merck exceeded Q3 expectations but adjusted its 2024 guidance downwards due to underwhelming revenues from Gardasil and Januvia. Novo is making progress in resolving shortages of Ozempic and Wegovy. Amgen is gearing up for…
  continue reading
 
Part 4 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug …
  continue reading
 
The organ shortage crisis is one of modern medicine's greatest challenges, but innovative technologies like 3D printing and AI are changing the game. Please visit our website to get more information: https://swangroup.net/ In this episode, I talk with Shola Oyewole, VP of Digital Innovation at United Therapeutics, to explore how they lead the charg…
  continue reading
 
Send us a text Struggling to unravel the complexities of your bioprocess? Prepare for a paradigm shift as we dive into the world of Process Analytical Technology (PAT) with Katharina Dahlmann who is Application and PAT Expert at Hamilton. This eye-opening episode dissects how PAT is redefining biologics manufacturing, balancing its immense potentia…
  continue reading
 
In this episode of Data in Biotech, Ross Katz sits down with Dave Johnson, CEO and co-founder of Dash Bio, a next-gen drug development services company with a mission to revolutionize clinical bioanalysis and streamline drug development. Dave begins the episode by taking us back to the early research days in Moderna, where he helped lay the groundw…
  continue reading
 
This week on BioTech Nation, Dr. Daniel Kraft talks about how AI can personalize health advice using data from devices like your smartwatch. He explains how this technology can help people make better choices to stay healthy and avoid major illnesses. Dr. Kraft envisions AI as a personal health coach, offering real-time tips and reminders tailored …
  continue reading
 
Biotech2050 Host, Rahul Chaturvedi, engages with Gene Mack, Interim CEO and CFO of Gain Therapeutics, as he shares his journey from aspiring neurosurgeon to biotech leader. Gene reflects on his career shift from clinical research to Wall Street and eventually operational roles in biotech. He details the development of Gain's lead asset, GT02287, wh…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer exceeded Wall Street's expectations in the third quarter, reporting higher revenue and adjusted profit amid pressure from activist investor Starboard Value. CEO Albert Bourla received a much-needed victory as the …
  continue reading
 
In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical en…
  continue reading
 
Ben Wiener is the founder and managing partner of JumpSpeed, the first and only venture capital fund dedicated to investing in early-stage startups in Jerusalem.Avraham sat down with Ben in the offices of JMB Davis Ben-David in Jerusalem to discuss why Ben started Jumpspeed, what he learned from investing in day one startups, his successes and fail…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie has acquired Aliada Therapeutics for $1.4 billion, gaining access to a phase I anti-amyloid antibody and a novel platform for efficient blood-brain barrier transport. Meanwhile, the FDA's accelerated approval progr…
  continue reading
 
Send us a text Unlock the hidden potential of your bioprocess! In this eye-opening episode, David Brühlmann sits down with Katharina Dahlmann, Application and PAT Expert at Hamilton, to explore the game-changing world of Process Analytical Technology (PAT). Discover how PAT is revolutionizing biotech by providing unprecedented insights into cell be…
  continue reading
 
We love to hear from our listeners. Send us a message. It might just be coincidence, but it sure seems like Bill Enright has a knack for making big moves at inopportune times, then turning the expected outcome on its ear. For example, he signed on as CEO at Altimmune when the company was struggling mightily. Enright had a turnaround plan in hand, b…
  continue reading
 
Part 3 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Sanofi beat third-quarter forecasts with a 381% growth in sales of its newly launched respiratory syncytial virus antibody, Beyfortus, bringing in almost $700 million. Analysts expect similar sales in the fourth quarter. …
  continue reading
 
In this milestone 100th episode, Karl and Erum look back on collaborations like the biosecurity event with Andrew Hessel and the U.S.-India Next Gen Materials event, while also acknowledging the establishment of the Chumash Heritage National Marine Sanctuary. Erum and Karl are also joined by special guest Dan Grushkin to explore the evolving world …
  continue reading
 
LinkGevity, founded by two sisters, is developing anti-necrotic technologies, especially for application in kidney disease. Carina Kern is the CEO of the company, while Serena Kern-Libera is the chief operating officer. After reading an article about how space-travel is especially damaging to the kidneys, they applied for a place on the inaugural N…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
  continue reading
 
Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.…
  continue reading
 
The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸. Get your unique referr…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche CEO opposes Novo Holdings' acquisition of Catalent, urging for it to be blocked. Roche exceeded Q3 sales expectations, driven by the success of drugs like Ocrevus and Vabysmo. Pfizer's RSV vaccine has been approved …
  continue reading
 
Send us a text Imagine predicting your bioprocess outcomes as easily as checking the weather forecast. Sound impossible? Not anymore. In this insightful episode, we dive deep into the world of digital twins and process models with Fabian Feidl, co-founder and CTO of DataHow. Discover how these cutting-edge tools are reshaping the biotech landscape,…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, follow…
  continue reading
 
Synopsis: Discover how Bitterroot Bio is poised to revolutionize cardiovascular health in this captivating conversation between host Rahul Chaturvedi and CEO Pavan Cheruvu. Pavan opens up about his inspiring journey from engineering to leading a biotech company at the forefront of cardio-immunology. Learn how his visionary leadership is driving inn…
  continue reading
 
How can biotech CEOs and their boards foster strong, trusting relationships that drive effective decision-making and long-term success? In this episode of Emerging Biotech Leader, host Kim Kushner explores this critical question together with Don de Bethizy. Don is a seasoned life sciences executive with over 30 years of experience, having served a…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchIn a groundbreaking study published in Nature Medicine, researchers have identified a new potential target for cancer therapy. This discovery could lead to more effective treatments for a…
  continue reading
 
Send us a text Are you ready to decode the future of bioprocessing? In this eye-opening episode, we dive deep into the world of digital bioprocess development with Fabian Feidl, co-founder and CTO of DataHow. Discover how cutting-edge process models are transforming the biotech industry, bridging the gap between raw data and actionable insights. Ke…
  continue reading
 
We love to hear from our listeners. Send us a message. While the trend toward CB1 inhibition for obesity took a small hit with the release of Novo Nordisk's small molecule oral cannabinoid receptor (CB1) inverse agonist monlunabant last month, Skye Bioscience Chairman and CEO Punit Dhillon is shaking it off. He's confident that his company's antibo…
  continue reading
 
Part 1 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## New Drug Approval: Title: FDA Approves New Cancer Drug for Treatment of Breast CancerContent: The FDA has approved a new cancer drug for the treatment of breast cancer. This new drug is expected to provide better outc…
  continue reading
 
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These tree…
  continue reading
 
In this episode, I explore 10 common resume mistakes that might be hindering your biotech job search. Drawing from my recent BioSpace column and observations, I offer practical advice on pitfalls to avoid, such as using profile pictures, fancy formatting, and not proofreading. I emphasize the importance of a professional email address and discuss t…
  continue reading
 
Erum and Karl reflect on their journey of producing nearly 100 episodes over two years. They discuss the challenges of consistency, the behind-the-scenes work required, and the evolution of their podcast from a simple idea to a platform that amplifies voices in the biotech space. Highlights include their gratitude to guests and collaborators, feedb…
  continue reading
 
Today, gene therapy is at an exciting inflection point as the industry moves beyond the first generation of these therapies. However, challenges and barriers remain in bringing gene therapies to market, particularly as they expand into more prevalent diseases. Spur Therapeutics is a clinical-stage biotech company dedicated to developing next genera…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. …
  continue reading
 
Synopsis: In this episode of Biotech 2050, Alex Martin, CEO of Abcuro, sits down with host Rahul Chaturvedi to share his inspiring journey from aspiring actor to biotech trailblazer. Alex reveals how his unique background shaped his leadership approach as he drives Abcuro’s groundbreaking work on Inclusion Body Myositis (IBM), a rare muscle disease…
  continue reading
 
Loading …

त्वरित संदर्भ मार्गदर्शिका